Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib

Brain. 2019 Nov 1;142(11):e59. doi: 10.1093/brain/awz293.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural
  • Comment

MeSH terms

  • Autoantibodies
  • Dermatomyositis*
  • Humans
  • Interferon Type I*
  • Piperidines
  • Pyrimidines
  • Pyrroles

Substances

  • Autoantibodies
  • Interferon Type I
  • Piperidines
  • Pyrimidines
  • Pyrroles
  • tofacitinib